Editorial
Copyright ©2010 Baishideng Publishing Group Co.
World J Clin Oncol. Feb 10, 2011; 2(2): 80-93
Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.80
Table 1 Single-targeted and multi-targeted inhibitors of cellular tyrosine kinases ABL, SRC and janus kinase family
InhibitorTyrosine kinase targetNeoplasm(s) targetedClinical status
Bcr-Abl inhibitors
Imatinib mesylate (STI571)Bcr-Abl, Kit, PDGFRβCML, ALL, GISTsApproved
Nilotinib (AMN107)BcrAbl, Kit, PDGFRβCML, Pcp ALL, HS, SMApproved
Tyrphostin AG1024Bcr-Abl, P-AktCML (refract to STI571)Preclinical
ON012380Bcr-AblCMLPhase I
Tyrphostin AG957Bcr-AblCMLPreclinical
AdaphostinBcr-AblCMLPreclinical
NS-187Bcr-Abl, LynCML, Pcp ALLPreclinical
SRC family inhibitors
Dasatinib (BMS354825)Bcr-Abl, SRCAdult CML, Pcp ALLApproved
SKI-606Bcr-Abl, SRCPcp leukemia, breastPhase I/II
AZD0530Bcr-Abl, SRCSolid tumorsPhase I
Lung, liver, colorectalPhase II
TG100435SRC, Lyn, abl, yes, lck, EphB4Anti-cancerPreclinical
PD166326Bcr-Abl, SRC, lynCMLPreclinical
PD180970Bcr-Abl, SRC, KitCMLPreclinical
AZM475271SRCPancreaticPreclinical
CGP76030Bcr-Abl, SRCCML, prost, bone metPreclinical
PP1FYN, Lck, Kit, Bcr-AblCMLPreclinical
PP2SRC, Lck, Fyn, HckColonPreclinical
AP-23236SRCBone metastasesPreclinical
PD173955 + 56BA, Kit, csk, PDGFRβ, EGFRCMLPreclinical
SU6656Scr, Fyn, Yes, LynLymphomaPreclinical
CGP77675SRCBonePreclinical
SU11333 + 36SRCBreast, colonPreclinical
JAK inhibitors
CP-690 550JAK3ImmunogenicPreclinical
AG-490JAK2/3, EGFRLeukemia, gliomaPreclinical
WHI-P154JAK3, Hck, SykNeural precursor cellsPreclinical
WHI-P131JAK3Leukemia, GVHDPreclinical
WP-1034JAK, StatAMLPreclinical
LFM-A13JAK2, BTKLeukemiaPreclinical